Ariosto S. Silva

2.3k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Ariosto S. Silva is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ariosto S. Silva has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Hematology and 8 papers in Oncology. Recurrent topics in Ariosto S. Silva's work include Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (6 papers) and Mathematical Biology Tumor Growth (5 papers). Ariosto S. Silva is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (6 papers) and Mathematical Biology Tumor Growth (5 papers). Ariosto S. Silva collaborates with scholars based in United States, Brazil and Puerto Rico. Ariosto S. Silva's co-authors include Robert A. Gatenby, Robert J. Gillies, B. Roy Frieden, José Andrés Yunes, Yoonseok Kam, Susan Minton, Kenneth H. Shain, Rachid Baz, Lia Perez and Maria L.C. Ribeiro and has published in prestigious journals such as Nature Communications, Bioinformatics and Cancer Research.

In The Last Decade

Ariosto S. Silva

20 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adaptive Therapy

2009 557 citations Robert A. Gatenby, Ariosto S. Silva et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariosto S. Silva United States	12	526	479	339	303	187	21	1.1k
Hiroshi Haeno Japan	13	310 0.6×	447 0.9×	142 0.4×	468 1.5×	47 0.3×	29	1.0k
Dewey Kim United States	12	463 0.9×	604 1.3×	109 0.3×	395 1.3×	293 1.6×	19	1.2k
Nancy G. Azizian United States	8	580 1.1×	1.5k 3.1×	76 0.2×	772 2.5×	128 0.7×	8	2.1k
Thomas G. Paulson United States	23	820 1.6×	966 2.0×	93 0.3×	627 2.1×	288 1.5×	37	2.6k
Irina Kareva United States	16	235 0.4×	307 0.6×	171 0.5×	362 1.2×	85 0.5×	44	836
Amanda Tracz United States	10	182 0.3×	283 0.6×	222 0.7×	227 0.7×	42 0.2×	14	679
Alexander Krasnitz United States	12	680 1.3×	1.3k 2.7×	31 0.1×	411 1.4×	209 1.1×	28	1.7k
Ioannis N. Anastopoulos United States	6	233 0.4×	678 1.4×	30 0.1×	235 0.8×	87 0.5×	8	896
Christopher D. McFarland United States	9	326 0.6×	443 0.9×	77 0.2×	143 0.5×	211 1.1×	14	693
Amin Yaqubie United States	6	178 0.3×	289 0.6×	91 0.3×	209 0.7×	59 0.3×	15	578

Countries citing papers authored by Ariosto S. Silva

Since Specialization

Citations

This map shows the geographic impact of Ariosto S. Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariosto S. Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariosto S. Silva more than expected).

Fields of papers citing papers by Ariosto S. Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariosto S. Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariosto S. Silva. The network helps show where Ariosto S. Silva may publish in the future.

Co-authorship network of co-authors of Ariosto S. Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Ariosto S. Silva. A scholar is included among the top collaborators of Ariosto S. Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariosto S. Silva. Ariosto S. Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Persi, Erez, Praneeth Sudalagunta, Yuri I. Wolf, et al.. (2025). Genome-level selection in tumors as a universal marker of resistance to therapy. Nature Communications. 16(1). 6535–6535. 1 indexed citations

Bishop, Ryan T., Tao Li, Praneeth Sudalagunta, et al.. (2024). Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma. Haematologica. 110(6). 1351–1367.

Li, Lin, Xiao Hu, Maciej Kmieciak, et al.. (2024). Combined MEK1/2 and ATR inhibition promotes myeloma cell death through a STAT3‐dependent mechanism in vitro and in vivo. British Journal of Haematology. 205(6). 2338–2348. 2 indexed citations

Yang, Guang, Samuel M. Rubinstein, Robert F. Cornell, et al.. (2023). Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma. Frontiers in Cardiovascular Medicine. 10. 1181806–1181806. 4 indexed citations

Sudalagunta, Praneeth, Carolina Silva, Rafael Renatino Canevarolo, et al.. (2022). CancerCellTracker: a brightfield time-lapse microscopy framework for cancer drug sensitivity estimation. Bioinformatics. 38(16). 4002–4010. 2 indexed citations

Meads, Mark B., Dario Magaletti, Joy Guingab‐Cagmat, et al.. (2021). Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma. Journal of Proteome Research. 20(6). 3134–3149. 10 indexed citations

Hasipek, Metis, Dale Grabowski, Yihong Guan, et al.. (2021). Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma. Cancers. 13(11). 2649–2649. 13 indexed citations

Sudalagunta, Praneeth, Maria Cláudia Silva, Rafael Renatino Canevarolo, et al.. (2020). A pharmacodynamic model of clinical synergy in multiple myeloma. EBioMedicine. 54. 102716–102716. 16 indexed citations

Shah, Bijal, Xiaohong Zhao, Ariosto S. Silva, Kenneth H. Shain, & Jianguo Tao. (2018). Resistance to Ibrutinib in B Cell Malignancies: One Size Does Not Fit All. Trends in cancer. 4(3). 197–206. 15 indexed citations

10.

Silva, Ariosto S., et al.. (2016). An Evolutionary Approach for Personalized Therapy in Multiple Myeloma. Applied Mathematics. 7(2). 159–169. 3 indexed citations

11.

Ribeiro, Maria L.C., Timothy Jacobson, Lori Hazlehurst, et al.. (2013). A Preclinical Assay for Chemosensitivity in Multiple Myeloma. Cancer Research. 74(1). 56–67. 42 indexed citations

12.

Silva, Ariosto S., et al.. (2012). Evolutionary Approaches to Prolong Progression-Free Survival in Breast Cancer. Cancer Research. 72(24). 6362–6370. 111 indexed citations

13.

Lee, Hyung‐Ok, Ariosto S. Silva, Yuesheng Li, et al.. (2011). Evolution of Tumor Invasiveness: The Adaptive Tumor Microenvironment Landscape Model. Cancer Research. 71(20). 6327–6337. 28 indexed citations

14.

Silva, Ariosto S., et al.. (2011). A multiscale model of the bone marrow and hematopoiesis. Mathematical Biosciences & Engineering. 8(2). 643–658. 15 indexed citations

15.

Silva, Ariosto S., Alexander R.A. Anderson, Robert J. Gillies, & Robert A. Gatenby. (2011). Abstract 21: Understanding the progression and chemotherapy resistance of Multiple Myeloma in the bone marrow through evolutionary computational models and in vitro experiments. Cancer Research. 71(8_Supplement). 21–21. 1 indexed citations

16.

Silva, Ariosto S. & Robert A. Gatenby. (2011). Adaptation to Survival in Germinal Center Is the Initial Step in Onset of Indolent Stage of Multiple Myeloma. Molecular Pharmaceutics. 8(6). 2012–2020. 9 indexed citations

17.

Silva, Ariosto S. & Robert A. Gatenby. (2010). A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biology Direct. 5(1). 25–25. 56 indexed citations

18.

Gatenby, Robert A., Ariosto S. Silva, Robert J. Gillies, & B. Roy Frieden. (2009). Adaptive Therapy. Cancer Research. 69(11). 4894–4903. 557 indexed citations breakdown →

19.

Silva, Ariosto S., José Andrés Yunes, Robert J. Gillies, & Robert A. Gatenby. (2009). The Potential Role of Systemic Buffers in Reducing Intratumoral Extracellular pH and Acid-Mediated Invasion. Cancer Research. 69(6). 2677–2684. 171 indexed citations

20.

Silva, Ariosto S., Robert A. Gatenby, Robert J. Gillies, & José Andrés Yunes. (2009). A quantitative theoretical model for the development of malignancy in ductal carcinoma in situ. Journal of Theoretical Biology. 262(4). 601–613. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact